1. Home
  2. KODK vs HELP Comparison

KODK vs HELP Comparison

Compare KODK & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$9.37

Market Cap

982.9M

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

HOLD

Current Price

$10.47

Market Cap

862.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
HELP
Founded
1880
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
862.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KODK
HELP
Price
$9.37
$10.47
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $41.40
AVG Volume (30 Days)
680.2K
★ 1.3M
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $4,114,000,000.00
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$6.60
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.78
$3.76
52 Week High
$14.87
$15.15

Technical Indicators

Market Signals
Indicator
KODK
HELP
Relative Strength Index (RSI) 50.29 43.27
Support Level $9.20 $9.97
Resistance Level $10.19 $14.75
Average True Range (ATR) 0.30 0.93
MACD 0.00 -0.05
Stochastic Oscillator 57.25 21.68

Price Performance

Historical Comparison
KODK
HELP

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: